Trial Profile
A Retrospective Study of Sorafenib in Racially diverse Patient population with Advanced Hepatocellular Carcinoma
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 23 Jul 2018
Price :
$35
*
At a glance
- Drugs Sorafenib (Primary)
- Indications Liver cancer
- Focus Adverse reactions; Therapeutic Use
- 23 Jul 2018 New trial record
- 01 Jul 2018 Results published in the Anticancer Research